Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-20-004834

Chief Medical Officer acquired 67,771 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brazzell Romulus K · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-09 Exercise or conversion : show line 1 in the form +1,880 $0.68 $1,278 110,605 D
2020-04-09 Exercise or conversion : show line 2 in the form +18,247 $2.30 $41,968 128,852 D
2020-04-09 Exercise or conversion : show line 3 in the form +47,644 $3.34 $159,131 176,496 D

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-04-09 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −1,880 $0.68 2023-05-09 1,880 0 D
2020-04-09 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −18,247 $2.30 2021-10-01 18,247 0 D
2020-04-09 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −47,644 $3.34 2026-06-16 47,677 13,508 D
Loading xslF345X03/edgar.xml…